Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 398 results found. Search for [ pfizer biontech covid 19 vaccine ]

Results 1 to 21 of 398
Reuters
February 24, 2021
AstraZeneca's statement late in the day said the company was striving to increase productivity to deliver the promised 180 million doses


Reuters
February 23, 2021
Data analysed by Public Health England (PHE) showed the Pfizer provided high levels of protection against infection and symptomatic disease from a single dose


Reuters
February 21, 2021
Up to 4 million Australians are expected to be inoculated by March, with Morrison among a small group receiving the first round of the Pfizer-BioNTech vaccine


Reuters
February 19, 2021
Symptoms, as reported in clinical trials for the AstraZeneca shot, can include a high temperature or headache and are a normal sign that the body is generating an immune response


Reuters
February 19, 2021
Phil Dormitzer, one of Pfizer's top viral vaccine scientists, said in an interview that he believes the current vaccine is highly likely to still protect against the concerning variant first discovered in South Africa


Rashi Bisaria
New Delhi, February 18, 2021
South African variant could significantly reduce vaccine protection, says Pfizer A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer-BioNTech vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday. Companies are making investments and talking to regulators about developing an updated version of their mRNA vaccine or a booster shot, if needed. COV...


Reuters
February 18, 2021
Pfizer and BioNTech said they were doing similar lab work to understand whether their vaccine is effective against another variant first found in Brazil


PTI
February 17, 2021
The vaccines currently approved for emergency use in India are Covishield, from the Oxford-AstraZeneca stable manufactured by Pune's Serum Institute of India, and Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology (NIV)


BusinessToday.In
February 17, 2021
National Intelligence Service (NIS), the chief intelligence agency of South Korea informed lawmakers about the alleged cyber breach on Tuesday, February 16, during a closed-door briefing to a parliamentary intelligence committee


BusinessToday.In
February 16, 2021
Serum Institute has applied for registration with Health Canada with the help of Toronto-based Verity Pharmaceuticals, Adar Poonawalla said


Chitranjan Kumar
February 15, 2021
COVID-19 vaccine: The AstraZeneca-Oxford product is a viral vectored vaccine called ChAdOx1-S [recombinant], which is being produced at several manufacturing sites, as well as in the Republic of Korea and India


Reuters
February 14, 2021
In December last year, Sanofi had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data


PTI
February 9, 2021
The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants carrying the N501Y and E484K mutations


Reuters
February 8, 2021
Prior to widespread circulation of the more contagious variant, the vaccine was showing efficacy of around 75%, researchers said


BusinessToday.In
New Delhi, February 5, 2021
Pfizer Inc has withdrawn its application for emergency-use authorization of its COVID-19 vaccine in India that it had developed with Germany's BioNTech. The US company, which was the first drugmaker to apply for emergency use authorization of its coronavirus vaccine in India, had a meeting with the country's drugs regulator on Wednesday and the decision was made after that, the company said. India's Central Drugs Standard Control Organisation had declined to accept Pfizer's request for approval without a small local trial on the vaccine's safety and immunogenicity for Indians. Watch the video for more.Also Read: Pfizer withdraws emergency use application for COVID-19 vaccine in India


PB Jayakumar
February 4, 2021
Coronavirus vaccine: India will get the maximum share of 97,164,000 doses (97.1 million), in addition to the direct orders placed by the Indian government with SII and Bharat Biotech


PTI
February 4, 2021
All manufacturers are looking at how they can improve their vaccine to make sure that we are ready for any variant - there are about 4,000 variants around the world of Covid now, Vaccine Deployment Minister Nadhim Zahawi told Sky


PTI
February 4, 2021
The yet-to-be peer-reviewed study, posted in the preprint repository medRxiv, assessed the antibody responses in 109 individuals with and without documented pre-existing immunity to the novel coronavirus


Reuters
February 4, 2021
The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world


BusinessToday.In
February 3, 2021
The Kingdom's interior ministry has announced temporary suspension of flights effective from 1800 GMT Wednesday. The country has also received first vaccine shipment delivery from Pfizer-BioNTech


PAGES 1 OF 20  12345